CBD (short for cannabidiol) is one of the cannabinoids, which are a group of over 200 chemical compounds found in cannabis. After THC (tetrahydrocannabinol), the psychoactive molecule in cannabis that gives people a high, it is the second most frequent active element identified in cannabis.
CBD has been related to the treatment of a wide range of medical conditions, including epilepsy, anxiety, inflammation, insomnia, and pain. Despite the fact that “credited” is not synonymous with “proven.” There are few well-conducted experiments to back up such claims due to the previous regulatory framework, but research is anticipated to increase now that hemp and marijuana are legally distinguishable. We look at nine medical conditions where CBD may be therapeutic or has already been proven to be beneficial.
Epidiolex (a plant-based formulation of CBD) was approved by the FDA in June 2018 to treat seizures in patients aged 2 and above who have Dravet syndrome or Lennox-Gastaut syndrome (LGS), two uncommon forms of epilepsy.
CBD has also been investigated for usage in a variety of kinds of treatment-resistant epilepsy, usually in conjunction with traditional epilepsy medications. Several trials revealed that CBD reduced seizure frequency by over 44 percent in the majority of patients, while the findings varied. CBD interacts with other epileptic medicines, and there have been reports of serious side effects, including a loss in liver function in people using valproate.
CBD has been shown in animal studies to have anti-inflammatory and pain-relieving qualities through interaction with the endocannabinoid and pain-sensing systems. Unfortunately, there are few human trials examining CBD’s efficacy as a solitary pain reliever, with the majority of research mixing CBD with THC to achieve pain relief.
Notably, Health Canada has approved a combination medication comprising THC and CBD in a 1:1 ratio for the treatment of central nerve pain in multiple sclerosis and cancer pain that has not responded to optimum opioid therapy. According to other research (both animal and human), CBD has anti-inflammatory qualities, and it may relieve pain through this mechanism.
Applying topical CBD to the skin has been found in animal tests to lessen the pain and inflammation associated with arthritis while having few side effects. Because CBD is poorly absorbed when taken orally and might cause gastrointestinal adverse effects, it is best used topically.
Pretreatment with 300mg CBD significantly lowered anxiety in 57 healthy males who took a simulated public speaking test. Doses of 150mg and 600mg CBD, on the other hand, had no effect on the men’s anxiety levels. CBD was proven to provide anti-anxiety effects in 21 patients out of 400 who reported anxiety in observational research.
Much other research, both on animals and humans, have found that White Label CBD has immunosuppressive and anti-inflammatory characteristics, making it a viable option for some autoimmune diseases and inflammation-related symptoms.